I have assembled material here from mainstream health sources, indicating that the Covid vax’s effectiveness, assuming it is effective at all, after 30 days was a mere 53 percent. It then dropped to 9 percent after 9 months. The mainstream medical technocrats are not phased and see this as a good reason for endless jabs. But, really, it contradicts the original narrative, given by the likes of Dr Fauci and Joe Biden, of the effectiveness of the vaccines in the first place. No other disease requires endless booster shots, so something must be wrong, especially given natural immunity gives a more robust and comprehensive response to the various strains of the great Covid family.
“Researchers affiliated with Northern Italian academic medical centers in Tento and Milan analyzed 40 studies in a systematic meta-analysis chronicling vaccination status and subsequent COVID-19 infection confirmed by standard testing. Covering periods during circulation of both the Delta and Omicron variants, the study was published in the peer-reviewed journal JAMA Network Open. On average vaccine effectiveness after 30 days was 53%. When it comes to protection against symptomatic COVID-19. This was regardless of COVID-19 vaccine, whether the mRNA vaccines (Pfizer-BioNTech, Moderna) or other COVID-19 jabs from AstraZeneca or Sinovac. The researchers represented by corresponding author Piero Poletti, PhD, Bruno Kessler Foundation reports that the investigators did detect variances among different vaccines. For example, on the higher end of performance, Moderna’s mRNA jab averaged 62% effective against symptomatic disease 30 days after vaccination; that performance waned considerably when looking at the Sinovac vaccine performance (32%) after 30 days. After six months vaccine performance is abhorrent, equaling 14% on average for all the vaccines, dropping further to 9% after nine months. Not surprisingly, the durability of the vaccines worsened during the Omicron stage versus the time when Delta was predominantly in circulation. While as with other studies, this meta-analysis revealed that administration of a booster dose of COVID-19 vaccine surge protection again to primary vaccination levels (60% at 30 days), unfortunately, and not surprisingly, this protection degraded rapidly (13% at nine months).
This study included numerous limitations. For example, the study team didn’t look into levels of protection associated with severe disease, hospitalization and death associated with COVID-19. TrialSite has reviewed numerous studies and the COVID-19 vaccines tend to perform somewhat better for longer periods of time against more serious, severe cases, but their performance does wane as well.”
https://twitter.com/EpochTimes/status/1654528883839102976
“These findings suggest that the effectiveness of COVID-19 vaccines…rapidly wanes over time.” The effectiveness of #COVID19 vaccines fell below 20% a few months after vaccination, with booster shots seeing effectiveness drop below 30%.
https://www1.racgp.org.au/newsgp/clinical/booster-protection-wanes-after-four-months-what-do
“The US CDC’s latest report on the durability of booster protection has found a more than 20% decline in effectiveness against emergency department encounters.
While much is known about protection against COVID-19 after two primary doses, the literature around booster shots is still in its infancy.
But a recent report, published by the US Centers for Disease Control and Prevention (CDC) on 11 February, is helping to shed some light on what the future may hold, with effectiveness found to wane after four months.
Researchers analysed 241,204 COVID-related emergency department (ED) and urgent care centre (UC) encounters, along with 93,408 hospitalisations from August 2021–January 2022 across 10 US states.
Among the ED/UC encounters and hospitalisations, 10% and 12% had received a booster, respectively.
Focusing on ED and UC visits from the Omicron surge specifically, researchers found vaccine effectiveness was 87% for people who had received a booster two months earlier – and dropped to 66% for those boosted four months earlier.
Similarly, vaccine effectiveness also fell for hospitalisations, down from 91% after two months to 78% after four.
So far, more than 10 million Australians over the age of 16 have received a third dose, and millions more are currently eligible. But with Chief Medical Officer Professor Paul Kelly predicting another Omicron wave during winter – which is just short of four months away – the research has raised questions about what the future may hold for Australia.
For now, experts are calling for calm, given that waning efficacy is to be expected, while highlighting that the findings still demonstrate a relatively high level of protection against severe illness.”
https://www.cdc.gov/mmwr/volumes/71/wr/mm7107e2.htm?s_cid=mm7107e2_w
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2804451
“Findings This systematic review and meta-analysis of secondary data from 40 studies found that the estimated vaccine effectiveness against both laboratory-confirmed Omicron infection and symptomatic disease was lower than 20% at 6 months from the administration of the primary vaccination cycle and less than 30% at 9 months from the administration of a booster dose. Compared with the Delta variant, a more prominent and quicker waning of protection was found.
Meaning These findings suggest that the effectiveness of COVID-19 vaccines against Omicron rapidly wanes over time.